- Advertisment -
HomeNationalA government panel may prescribe covovacs as a heterologous booster dose for...

A government panel may prescribe covovacs as a heterologous booster dose for adults skf mgbAchi News

- Advertisment -

A government panel may prescribe covovacs as a heterologous booster dose for adults skf mgb

In the Corona threat, the decision on 'Covax' is used today as a reinforcement measure!

In the Corona threat, the decision on ‘Covax’ is used today as a reinforcement measure!

Covex is manufactured by the Serum Institute through technology transfer from Novex.

  • News18 Urdu
  • Last Updated:
  • New Delhi, India
A government panel may decide today (January 11) the dose of corona protection for adults at risk of corona on covas. An expert panel of the Central Drug Regulatory Authority is likely to decide on Wednesday whether the Serum Institute of India (SII) has approved the launch of the Corona vaccine ‘Covax’ in the market. A dose of Covex can be given to people who have taken either CoviShield or Covexin, official sources said.

The subject expert committee meeting of the Central Drug Standardization Organization (CDSCO) has decided to be held today on January 11. Prakash Kumar Singh, director of government and regulatory affairs at the Serum Institute of India (SII), recently wrote a letter to the Drug Controller General of India (DGCI) asking them to use the drug as a booster dose for adults. Kovacs asked for approval. An official source said that there was an appeal for an immediate decision on this as the epidemic is worsening in some countries.

Approved by DCGI for adult use in emergency situations on 28 December 2021. Kovacs was then approved on March 9, 2022 under certain conditions for people aged 12-17 years and again on June 28, 2022 for children aged 7-11 years.

Also Read:
The world is at risk of a new wave of coronavirus, according to the World Health Organization. The new variant is very dangerous

Also Read:
In West Bengal, four new cases of Corona BF.7, which entered India from America, have been found

Covex is manufactured by the Serum Institute through technology transfer from Novex. It has been approved for conditional marketing authorization by the European Medicines Agency. It was added to the emergency use list by the World Health Organization (WHO) on 17 December 2021.

Published by:Sheikh Khalil Farhad

First published:

.

- Advertisment -